Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of Predominantly African American Population with Multiple Myeloma.

Anshul Bamrolia, MD, Ahmad Jajeh, MD, R. Catchatourian, MD, David Osafo, MD, Deimante Tamkus, MD, Neelesh Sharma, MD, Ghassan Zalzaleh, MD, Sunita Nathan, MD, Perry Menini, MD

Blood (2006) 108 (11): 5105.

https://doi.org/10.1182/blood.V108.11.5105.5105

Published: 2006

Journal Articles

Cytogenetics in Adult De Novo Acute Myeloid Leukemia: An Institutional Experience of a Predominantly Minority Population.

Ebenezer Berko, MD, David Osafo, MD, Deimante Tamkus, MD, Decebal S. Griza, MD, Steven Sloan, MD, Ahmad Jajeh, MD, Paula Kovarik, MD, Rose Catchatourian, MD

Blood (2005) 106 (11): 4484.

https://doi.org/10.1182/blood.V106.11.4484.4484

Published: 2005

Journal Articles

Retreatment with Gemcitabine Still Hold Efficacy in Relapsed Lymphomas.

Ahmad Jajeh, MD, MPH, Diemanti Tamkus, MD, Perry Menini, MD, David Osafo, MD.

Blood (2005) 106 (11): 4751.

https://doi.org/10.1182/blood.V106.11.4751.4751

Published: 2005

Journal Articles

Adult Acute Lymphoblastic Leukemia and Cytogenetic Abnormalities in Different Racial and Ethnic Subgroups.

Deimante Tamkus, MD, Ahmad Jajeh, MD, Ebenezer Berko, MD, David Osafo, MD, Decebal Griza, Paula Kovarik, MD, Rose Catchatourian, MD

Blood (2005) 106 (11): 4547.

https://doi.org/10.1182/blood.V106.11.4547.4547

Published: 2005

Journal Articles

Thalidomide Response in African American Patients with Multiple Myeloma.

Ahmad Jajeh, MD, MPH, Rose Catchatourian, MD, Deimante Tamkus, MD, David Osafo, MD, Ghassan Zalzaleh, MD, Barbara Yim, PharmD

Blood (2005) 106 (11): 5147.

https://doi.org/10.1182/blood.V106.11.5147.5147

Published: 2005

Journal Articles

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of a Predominantly African American Population with Multiple Myeloma.

Ahmad Jajeh, MD, MPH, Rosalind Catchatourian, MD, David Osafo, MD, Deimante Tamkus, MD, Ghassan Zalzaleh, MD, Anshul Bamrolia, MD

Blood (2005) 106 (11): 2573.

https://doi.org/10.1182/blood.V106.11.2573.2573

Published: 2005

Journal Articles

Pentostatine Is a Safe and Active Agent in Chronic Lymphocytic Leukemia CLL with Minimal Toxicity.

Ahmad Jajeh, MD, MPH, Deimante Tamkus, MD, Ebinezer Berko, MD, Alusola Ogandipe, MD, David Osafo, MD, Barbara Yim, PharmD, Ghassan Zalzaleh, MD

Blood (2005) 106 (11): 5042.

https://doi.org/10.1182/blood.V106.11.5042.5042

Published: 2005

NARROW

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of Predominantly African American Population with Multiple Myeloma.

Cytogenetics in Adult De Novo Acute Myeloid Leukemia: An Institutional Experience of a Predominantly Minority Population.

Retreatment with Gemcitabine Still Hold Efficacy in Relapsed Lymphomas.

Adult Acute Lymphoblastic Leukemia and Cytogenetic Abnormalities in Different Racial and Ethnic Subgroups.

Thalidomide Response in African American Patients with Multiple Myeloma.

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of a Predominantly African American Population with Multiple Myeloma.

Pentostatine Is a Safe and Active Agent in Chronic Lymphocytic Leukemia CLL with Minimal Toxicity.

Email alerts

ASH Publications

American Society of Hematology

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of Predominantly African American Population with Multiple Myeloma.

Cytogenetics in Adult De Novo Acute Myeloid Leukemia: An Institutional Experience of a Predominantly Minority Population.

Retreatment with Gemcitabine Still Hold Efficacy in Relapsed Lymphomas.

Adult Acute Lymphoblastic Leukemia and Cytogenetic Abnormalities in Different Racial and Ethnic Subgroups.

Thalidomide Response in African American Patients with Multiple Myeloma.

Pegylated Liposomal Doxorubicin (PLD), Vincristine and Reduced-Dose Dexamethasone (DVd) in the Treatment of a Predominantly African American Population with Multiple Myeloma.

Pentostatine Is a Safe and Active Agent in Chronic Lymphocytic Leukemia CLL with Minimal Toxicity.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only